Preparation and preclinical evaluation of 18F-labeled folate-RGD peptide conjugate for PET imaging of triple-negative breast carcinoma
Our findings suggest that the [<sup>18</sup>F]FDG-labeled FA-RGD peptide conjugate can be a useful agent for the efficient targeting of TNBC cells. This study suggests the potential of this innovative heteromeric targeting agent for rapid and efficient targeting of tumors and merits further advancement.
Authors
- Subhani M. Okarvi (ORCID: https://orcid.org/0000-0001-7980-5917)
- Yousef Maliki
Institutions
- King Faisal Specialist Hospital & Research Centre (SA)
Publication Details
- Journal
- EJNMMI Radiopharmacy and Chemistry
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1186/s41181-025-00349-4
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00